POLR2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.092100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.541700E-02
Normal-vs-Stage2
3.337600E-02
Normal-vs-Stage3
8.004800E-03
Normal-vs-Stage4
4.337600E-01
Stage1-vs-Stage2
9.232000E-01
Stage1-vs-Stage3
2.690000E-02
Stage1-vs-Stage4
2.250200E-01
Stage2-vs-Stage3
7.179700E-02
Stage2-vs-Stage4
1.931960E-01
Stage3-vs-Stage4
2.018000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.623800E-02
Normal-vs-AfricanAmerican
1.910440E-01
Normal-vs-Asian
1.109400E-01
Caucasian-vs-AfricanAmerican
4.289400E-01
Caucasian-vs-Asian
7.530400E-01
AfricanAmerican-vs-Asian
4.935400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.604410E-02
Normal-vs-Female
6.221900E-02
Male-vs-Female
5.489600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.420000E-02
Normal-vs-Age(41-60Yrs)
1.154620E-01
Normal-vs-Age(61-80Yrs)
1.457900E-02
Normal-vs-Age(81-100Yrs)
4.889500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.997800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.854000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.691800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.457700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.131400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.694400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.086100E-02
Normal-vs-Daily Drinker
3.377000E-03
Normal-vs-Weekly Drinker
6.331900E-02
Normal-vs-Occasional Drinker
1.030610E-01
Normal-vs-Social Drinker
3.392400E-02
Non Drinker-vs-Daily Drinker
4.052400E-01
Non Drinker-vs-Weekly Drinker
7.989600E-01
Non Drinker-vs-Occasional Drinker
2.468400E-01
Non Drinker-vs-Social Drinker
4.342000E-01
Daily Drinker-vs-Weekly Drinker
2.630800E-01
Daily Drinker-vs-Occasional Drinker
2.092000E-02
Daily Drinker-vs-Social Drinker
7.059600E-02
Weekly Drinker-vs-Occasional Drinker
3.776000E-01
Weekly Drinker-vs-Social Drinker
6.704800E-01
Occasional Drinker-vs-Social Drinker
5.838400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.214200E-01
Normal-vs-Grade 2
6.662200E-01
Normal-vs-Grade 3
1.735410E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.482400E-01
Grade 1-vs-Grade 3
3.766200E-01
Grade 1-vs-Grade 4
3.214200E-01
Grade 2-vs-Grade 3
1.756010E-01
Grade 2-vs-Grade 4
6.662200E-01
Grade 3-vs-Grade 4
1.735410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.562900E-03
Normal-vs-NonDiabetic
2.342200E-02
Diabetic-vs-NonDiabetic
5.509400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.401500E-03
Normal-vs-NoPancreatitis
2.742100E-02
Pancreatitis-vs-NoPancreatitis
3.847200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.674300E-02
Normal-vs-N1
3.173900E-02
N0-vs-N1
8.128800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.208000E-02
Normal-vs-TP53-NonMutant
1.268400E-01
TP53-Mutant-vs-TP53-NonMutant
1.737750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
